Acelrx Pharmaceuticals, Inc. 401(K) Plan — Form 5500 plan (Acelrx Pharmaceuticals, Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Acelrx Pharmaceuticals, Inc. 401(K) Plan is a benefit plan reported by Acelrx Pharmaceuticals, Inc. under EIN 41-2193603 and plan number 001. The latest loaded filing year is 2023. The filing reports 55 participants and $7,694,297 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Acelrx Pharmaceuticals, Inc.
- EIN
- 41-2193603
- Plan number
- 001
- Plan type
- 2
- Location
- Hayward, CA
- Latest filing year
- 2023
How to read this plan profile
- Net assets = total assets minus total liabilities, end of year (Schedule H/I).
- Assets / participant is computed (assets ÷ reported participants) — a ratio, not a filed figure.
- Schedule chips (Sch H / I / C) show which schedules each filing includes.
- Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
- Figures are reported as filed, in whole dollars; verify against the official DOL/EBSA record before relying on them.
Form 5500 filing history
Each loaded annual filing for this plan. Open one for its full reported snapshot.
- 2023Sch IView filing →
Reported financial statement
Reported figures as filed, in whole dollars. Only fields the filing reports are shown; others are marked not reported.
Full reported line items
Net assets
- Total assets (EOY)
- $7,694,297
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $7,694,297
- Net assets (BOY)
- $7,979,075
Income & contributions
- Employer contributions
- $183,154
- Participant contributions
- $325,383
- Total income / additions
- $1,797,609
Expenses & distributions
- Benefits paid
- $2,053,152
- Administrative expenses
- $29,235
- Total expenses
- $2,082,387
- Net increase / (decrease)
- -$284,778
Reported ratios
Derived only from this plan's own reported figures — comparisons within the filing, not benchmarks, estimates, or national averages.
Service provider compensation
Reported direct + indirect compensation per provider, ranked. Bars show relative scale.
No Schedule C service provider compensation is loaded for this plan yet.
Frequently asked questions
- Who sponsors the Acelrx Pharmaceuticals, Inc. 401(K) Plan?
- Acelrx Pharmaceuticals, Inc. 401(K) Plan is reported as sponsored by Acelrx Pharmaceuticals, Inc. (EIN 41-2193603, plan number 001) in public Form 5500 filings.
- What is the most recent Form 5500 filing year for Acelrx Pharmaceuticals, Inc. 401(K) Plan?
- The latest Form 5500 filing year loaded for Acelrx Pharmaceuticals, Inc. 401(K) Plan is 2023.
- How many participants does Acelrx Pharmaceuticals, Inc. 401(K) Plan report?
- Acelrx Pharmaceuticals, Inc. 401(K) Plan reports 55 participants in its latest loaded Form 5500 filing.
- What are the reported plan assets for Acelrx Pharmaceuticals, Inc. 401(K) Plan?
- Acelrx Pharmaceuticals, Inc. 401(K) Plan reports $7,694,297 in end-of-year plan assets in its latest loaded Form 5500 filing.
Form 5500 terms, in plain English
- Form 5500
- The annual report most U.S. employee benefit plans file with the Department of Labor through the EFAST2 system. It documents the plan sponsor, participants, finances, and service-provider compensation.
- Schedule H
- The financial statement for larger plans (generally 100+ participants): assets, liabilities, net assets, income, expenses, and the net change.
- Schedule I
- The condensed financial statement for smaller plans, covering the same kinds of figures in less detail.
- Schedule C
- Reports compensation paid to the plan’s service providers — both direct and indirect.
- Net assets
- Total assets minus total liabilities at the end of the year — what the plan holds for participants.
- Employer / participant contributions
- Money contributed to the plan by the employer and by participants during the year.
Figures are reported as filed and may contain errors or omissions. Verify against the official DOL/EBSA record before relying on any value.